Overexpression of the antiapoptotic gene Bfl-1 in B cells from patients with familial systemic lupus erythematosus

Abstract

Genetic determinants taking part in the development of systemic lupus erythematosus (SLE) are complex and not fully characterized. Dysregulated expression of genes involved in the control of apoptosis has been previously suggested. We report here a consanguineous family with SLE manifestations in three siblings associated in one of them with severe lymphoproliferative features. Laboratory studies showed no defect in CD95-mediated cell death. Screening expression of Bcl-2 family genes that regulate mitochondrial apoptosis pathway showed an overexpression of the antiapoptotic Bfl-1 gene. Real time RT-PCR analysis indicated that overexpression of Bfl-1 was restricted to B-cells, with normal expression in T-cells. Those results suggest that overexpression of Bfl-1 could result in impaired B-lymphocyte homeostasis and inappropriate immune response leading to autoimmune manifestations.

Keywords

apoptosis B-cells Bfl-1 Bcl-2 lupus

Get full access to this article

View all access options for this article.

References

Qing X , Putterman C . Gene expression profiling in the study of the pathogenesis of systemic lupus erythematosus. Autoimmun Rev 2004; 3: 505–509.

Thatayatikom A , White AJ . Rituximab: a promising therapy in systemic lupus erythematosus. Autoimmun Rev 2006; 5: 18–24.

Bidere N , Su HC , Lenardo MJ . Genetic disorders of programmed cell death in the immune system. Annu Rev Immunol 2006; 24: 321–352.

Rieux-Laucat F , Le Deist F , Fischer A . Autoimmune lymphoproliferative syndromes: genetic defects of apoptosis pathways. Cell Death Differ 2003; 10: 124–133.

Wu J , Wilson J , He J , Xiang L , Schur PH , Mountz JD . Fas ligand mutation in a patient with systemic lupus erythematosus and lymphoproliferative disease. J Clin Invest 1996; 98: 1107–1113.

Del-Rey M , Ruiz-Contreras J , Bosque A et al. A homozygous Fas ligand gene mutation in a patient causes a new type of autoimmune lymphoproliferative syndrome. Blood 2006; 108: 1306–1312.

Mehrian R , Quismorio FP Jr , Strassmann G et al. Synergistic effect between IL-10 and bcl-2 genotypes in determining susceptibility to systemic lupus erythematosus. Arthritis Rheum 1998; 41: 596–602.

Johansson C , Castillejo-Lopez C , Johanneson B et al. Association analysis with microsatellite and SNP markers does not support the involvement of BCL-2 in systemic lupus erythematosus in Mexican and Swedish patients and their families. Genes Immun 2000; 1: 380–385.

Trescol-Biemont MC , Verschelde C , Cottalorda A , Bonnefoy-Berard N . Regulation of A1/Bfl-1 expression in peripheral splenic B cells. Biochimie 2004; 86: 287–294.

10.

Cottalorda A , Verschelde C , Marcais A et al. TLR2 engagement on CD8 T cells lowers the threshold for optimal antigen-induced T cell activation. Eur J Immunol 2006; 36: 1684–1693.

11.

Choi SS , Park IC , Yun JW , Sung YC , Hong SI , Shin HS . A novel Bcl-2 related gene, Bfl-1, is overexpressed in stomach cancer and preferentially expressed in bone marrow. Oncogene 1995; 11: 1693–1698.

12.

Feuerhake F , Kutok JL , Monti S et al. NF{kappa}B activity, function and target gene signatures in primary mediastinal large B-cell lymphoma and diffuse large B-cell lymphoma subtypes. Blood 2005; 106: 1392–1399.

13.

Monti S , Savage KJ , Kutok JL et al. Molecular profiling of diffuse large B-cell lymphoma identifies robust subtypes including one characterized by host inflammatory response. Blood 2005; 105: 1851–1861.

14.

Morales AA , Olsson A , Celsing F , Osterborg A , Jondal M , Osorio LM . High expression of bfl-1 contributes to the apoptosis resistant phenotype in B-cell chronic lymphocytic leukemia. Int J Cancer 2005; 113: 730–737.

15.

Baker KP . BLyS–an essential survival factor for B cells: basic biology, links to pathology and therapeutic target. Autoimmun Rev 2004; 3: 368–375.